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Methylxanthines are shown in this study to decrease cholesterol synthesis in cultured C-6 glial cells. Aminophylline (10-3M) produced a rapid decline in cholesterol synthesis so that by 6 hr, synthesis in treated cells was less than 20% of that in untreated cells, and by 24 hr, less than 10%. Aminophylline induced parallel changes in 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase activity, the rate-limiting enzyme in cholesterol synthesis. Theophylline and caffeine produced similar effects. Thus, methyxanthines caused a specific, enzyme-mediated reduction in cholesterol synthesis in C-6 glia. In an attempt to relate the methylxanthines' effect on cultured glial cells to the developing nervous system, cholesterol synthesis was studied in the presence of 10-4M aminophylline. This represents a theophylline concentration in the culture medium that is of the same order of magnitude a s that produced in whole brain of animals administered therapeutic doses of aminophylline. Under these conditions, cholesterol synthesis was reduced to approximately 60% of control after 48 and 72 hr.
Speculation
Cholesterol is the major lipid constituent of myelin and other cell membranes and reduction in synthesis of this lipid could have deleterious effects. C-6 glia are models of the glial stem cell found in developing brain before myelination, e.g., human brain in the perinatal period. This study raises the question whether serious reductions in brain cholesterol synthesis occur in vivo during the treatment of neonatal apnea.
Methylxanthines, such as theophylline, aminophylline, and caffeine, currently are used extensively in the treatment of apnea in the neonatal period (1, 6, 7, 10, 15, 17) . However, little is known about potential long and short-term effects of this class of drugs on the developing brain. The methylxanthines are known central nervous system stimulants (13) and have effects on enzyme systems and hormone release in organs other than the brain (14) . These extraneural effects are produced primarily by inhibition of adenosine 3'5'-monophosphate (CAMP) phosphodiesterase and potentiation of the action of CAMP (14) . The major biochemical effects of methylxanthines on the central nervous system remain to be elucidated.
The neonatal period is a time of active membrane proliferation and the onset of myelination in the human brain (5) . A major lipid constituent of all cellular membranes, including myelin, is cholesterol. It is known that cholesterol of the developing brain is derived primarily from de novo synthesis, primarily in the glial elements of the brain (5) .
Because of these facts, the present study of C-6 glial cells was undertaken with the following objectives: 1) to determine whether methylxanthines regulate cholesterol synthesis; 2) to define the enzymatic site of any regulatory effects; and 3) to determine the drugs.-C-6 giial cells in culture were utilized to avoid the problems of cellular heterogeneity encountered in studies of whole brain or brain slices. Moreover, because C-6 glial cells exhibit properties of both oligodendroglia and astrocytes (3, 18, 23) . they are considered to be good models of the stem cell that gives rise to these glial types and that is found in developing brain. CELL CULTURE C-6 glial cells were purchased from American Type Culture Collection, Rockville, MD. The methods of cell culture have been described (21, 22) . C-6 glial cells have been adapted to growth in a basal medium free of serum. The medium is composed of glucose, gluconolactone, amino acids, vitamins. inositol, pyruvate, and various inorganic salts.
For each experiment, cells were derived from a single flask. The size of each inoculum was identical and adjusted to give a final concentration of 0.5 x 10' cells/ml in either 25-or 75-cm' flasks. The former were used for all measurements of cholesterol and protein synthesis and the latter for all determinations of HMgCoA reductase activity.
PREPARATION OF CELL EXTRACTS FOR ENZYME ASSAYS
Cells were harvested with EDTA (0.02% w/v) as described (21) and centrifuged at 1500 rpm for 10 min. The cell pellet was frozen in liquid nitrogen, thawed, and resuspended in 200 p1 of buffer (50 mM potassium phosphate, pH 7.5, 5 mM dithiothreitol. I mM EDTA, and 0.25% Kyro-EOB) as described by Brown et al. (4) .
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HMG-COA REDUCTASE ASSAY
reduced to less than 20% of control values. and bv 24 hr. to less The enzyme was assayed in cell extracts by the method of Brown et al. (4) as modified in the authors' laboratory (19) . The radioactive product ([14C]mevalonic acid) was separated from the radioactive substrate (['4C]HMG-CoA) by a modification (9) of the ion-exchange procedure of Avigan et al. (2) . Recovery of the reaction product was adjusted to 100% by use of the internal standard (["Hlmevalonate).
PROTEIN DETERMINATION
Protein in cellular extracts was determined by the method of Lowry et al. (8) .
CHOLESTEROL SYNTHESIS
The synthesis of cholesterol in C-6 glia was determined by measuring the incorporation of [I-'4C]acetate or W2O into digitonin precipitable sterols after pulsing the cells for 2 or 3 hr, respectively. The cells were harvested by the addition of 2 ml of 2N NaOH to the flasks. Digitonin precipitation was performed by the method of Popjak (12), as modified (16) .
PROTEIN SYNTHESIS
The synthesis of protein was determined by measuring incorporation of 3H20 into trichloroacetic acid precipitable material (20) .
STATISTICAL PROCEDURES
Statistical significance was determined by Student's t test. The data presented in the tables and figures were subjected to this analysis and all differences discussed in the text are significant at the P < 0.01 level or better.
RESULTS
Initially, the effect of 10-"M aminophylline on cholesterol synthesis in C-6 glial cells as a function of time of exposure to the drug was determined (Fig. 1) . A rapid decline in cholesterol synthesis occurred in the treated cells. By 6 hr synthesis was than 10%.
Next, the possibility was considered that such dramatic and rapid effects were related to a nonspecific alteration in cellular uptake of [14C]acetate, its activation to acetyl-CoA, or to changes in intracellular pool sizes. Thus, the effect of aminophylline on cholesterol synthesis was examined at 6 hr with "H20 as recursor.
P .
At the same time, in separate flasks, incorporation o f ' H 2 0 Into protein was measured to determine the specificity of aminophylline's effect on cholesterol synthesis (Table 1) . Cholesterol synthesis from "HzO was reduced more than 2-fold after 6 hr of exposure to aminophylline. This effect is similar to that observed with [I4C] acetate. Moreover, the inhibitory effect on cholesterol synthesis was not accompanied by any alteration in total protein synthesis.
To establish further that the reduction of cholesterol svnthesis induced by methylxanthines is a specific regulatory effect and not a nonspecific toxic effect, the reversibility of the changes was evaluated (Fig. 2) . Thus, the cells were exposed to 10-"M aminophylline for 6 hr. This caused a reduction in cholesterol synthes,, to 20% of control values. The glia were then washed with buffer and placed in medium free of arninophylline. Cholesterol synthesis recovered dramatically within 18 hr of removal of the drug and was complete by 72 hr.
To define the enzymatic site of aminophylline's action, its effect on the rate-limiting enzyme, HMG-CoA reductase was evaluated (Table 2 ). After exposure of the cells to the drug for 2, 6, and 24 hr, reductase activity was observed to be 102,30, and 9% of control values, respectively. The decreases in reductase activity seen at 6 and 24 hr correlate closely with the decreases in cholesterol synthesis described previously (see Fig. I ). The other clinically utilized methylxanthines, theophylline, and caffeine, were also shown to cause a decrease in reductase activity after 24 hr of exposure to C-6 glia (Table 3) . Thus, 10-3M theophylline resulted in a decrease of reductase activity to 21% of control values, and 10-"M caffeine, to 17%.
Finally, to approximate more closely the in vivo situation, cholesterol synthesis in glia exposed to a concentration of aminophylline (10-4M) that is more nearly similar to that found in blood and brain of animals treated with therapeuutic doses of the drug was measured (I I) ( Table 4 ). Despite the 10-fold lower concentra- Table 2 
DISCUSSION
This study has dealt with regulation by methylxanthines of cholesterol synthesis in cultured C-6 glial cells. Cells exposed to these drugs at 10-M for only 6 hr exhibit a marked reduction in cholesterol synthesis. This effect was shown to be accompanied by a comparable change in the activity of HMG-CoA reductase, the rate-limiting enzyme in the cholesterol biosynthetic pathway. The effect was re~roduced with "H?O as precursor for measurements of cholesterol synthesis. In contrast, no effect on protein synthesis occurred under similar conditions. In addition, cholesterol synthesis in the treated cells was shown to recover completely after removal of the drug. These data suggest that methylxanthines have a specific regulatory effect on cholesterol biosynthesis in C-6 glial cells and that the site of their action is HMG-CoA reductase.
Cholesterol is a major lipid constituent of myelin and all cellular membranes. Thus, a reduction in cholesterol synthesis could have significant deleterious effects on membrane production and myelination. C-6 glial cells exhibit many of the characteristics of the glial stem cell found in the developing nervous system just before myelination. Thus, inhibition of cholesterol synthesis in C-6 glial raises the question: do such effects occur in vivo and, more specifically, in newborns administered methylxanthines for the treatment of apnea?
Because of this latter question, aminophylline's effect on glial cholesterol synthesis at a concentration of 10-4M was investigated. Intracellular concentrations of methylxanthines in vivo under therapeutic conditions are unknown. However, Neese and Soyka (I I) have determined concentrations of aminophylline in whole brain of 10-day-old mice administered a dose of 4 mg/kg rectally and found the levels to be 18.8 pg/g tissue wt at 15 min and 14.3 pg/ g at 120 min after drug administration. Brain:blood ratios of the drug were found generally to be slightly greater than unity. This suggests that blood levels are a good approximation of brain levels. Currently, it is suggested that theophylline blood levels be maintained in the range of 10-20 pg/ml in treating neonatal apnea (16) . Thus, 10-4M aminophylline (38 pg/ml of theophylline) is of a similar order of magnitude. The fact that 10-4M aminophylline decreases cholesterol synthesis significantly in cultured glial cells raises the possibility that therapeutic levels of methylxanthines may have similar effects in vivo.
